ReviewSub-cellular biochemistry2025
Role of Nuclear Lamins in the Regulation of the Genome: Focus on CardioLaminopathy.
Review in Sub-cellular biochemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nuclear lamins, the unique type 5 intermediate filaments of the nucleus, form a structural network beneath the nuclear envelope. Through their strategic localization, they interact with numerous partners and regulate a wide range of biochemical and biophysical processes. In load-bearing tissues such as the heart, nuclear lamins are crucial for maintaining mechanical integrity and genome stability during cardiac contraction. By associating with chromatin through lamina-associated domains, they play a fundamental role in genome organization and gene expression. Disruption of the nuclear lamin meshwork in CardioLaminopathy leads to chromatin remodeling and dysregulated gene expression. Although the precise cellular and molecular mechanisms driving CardioLaminopathy remain incompletely understood, alterations in genome organization are emerging as key contributors to disease pathogenesis and progression.
Indexed as
Identifiers
41004037What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.